Íñigo-Catalina, L.; Ortiz-Cabello, M.; Navarro, E.; Esteras, N.; Rancan, L.; Paredes, S.D.
Melatonin-Mediated Nrf2 Activation as a Potential Therapeutic Strategy in Mutation-Driven Neurodegenerative Diseases. Antioxidants 2025, 14, 1190.
https://doi.org/10.3390/antiox14101190
AMA Style
Íñigo-Catalina L, Ortiz-Cabello M, Navarro E, Esteras N, Rancan L, Paredes SD.
Melatonin-Mediated Nrf2 Activation as a Potential Therapeutic Strategy in Mutation-Driven Neurodegenerative Diseases. Antioxidants. 2025; 14(10):1190.
https://doi.org/10.3390/antiox14101190
Chicago/Turabian Style
Íñigo-Catalina, Lucía, María Ortiz-Cabello, Elisa Navarro, Noemí Esteras, Lisa Rancan, and Sergio D. Paredes.
2025. "Melatonin-Mediated Nrf2 Activation as a Potential Therapeutic Strategy in Mutation-Driven Neurodegenerative Diseases" Antioxidants 14, no. 10: 1190.
https://doi.org/10.3390/antiox14101190
APA Style
Íñigo-Catalina, L., Ortiz-Cabello, M., Navarro, E., Esteras, N., Rancan, L., & Paredes, S. D.
(2025). Melatonin-Mediated Nrf2 Activation as a Potential Therapeutic Strategy in Mutation-Driven Neurodegenerative Diseases. Antioxidants, 14(10), 1190.
https://doi.org/10.3390/antiox14101190
